S100A12 and Soluble Receptor for Advanced Glycation End Products Levels During Human Severe Sepsis

A Monoclonal Antibody Against RAGE Alters Gene Expression and is Protective in Experimental Models of Sepsis and Pneumococcal Pneumonia

(2011) Eirini Christaki et al.   SHOCK

Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients

(2010) A. Nakashima et al.   Clinical Journal of the American Society of Nephrology

Significance of Measuring S100A12 and sRAGE in the Serum of Sepsis Patients with Postoperative Acute Lung Injury

(2010) Tomohiro Kikkawa et al.   DIGESTIVE SURGERY

Expression and Role of Myeloid-related Protein-14 in Clinical and Experimental Sepsis

(2009) Marieke A. D. van Zoelen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Introduction: Sepsis

(2009) Glenn S. Tillotson   CHEST

The Receptor for Advanced Glycation End Products Impairs Host Defense in Pneumococcal Pneumonia

(2009) M. A. D. van Zoelen et al.   JOURNAL OF IMMUNOLOGY

Receptor for Advanced Glycation End Products Facilitates Host Defense duringEscherichia coli–Induced Abdominal Sepsis in Mice

(2009) Marieke A. D. van Zoelen et al.   JOURNAL OF INFECTIOUS DISEASES

Compartmental Apoptosis and Neutrophil Accumulation in Severe Peritonitis

(2009) J.W. Olivier van Till et al.   JOURNAL OF SURGICAL RESEARCH

Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia

(2009) Marieke A.D van Zoelen et al.   VIROLOGY

Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis

(2008) Yasukiyo Mori et al.   AMERICAN JOURNAL OF NEPHROLOGY

Human S100A12: a novel key player in inflammation?

(2008) Jens Pietzsch et al.   AMINO ACIDS

Gene profiling in human blood leucocytes during recovery from septic shock

(2008) Didier Payen et al.   INTENSIVE CARE MEDICINE

Identification, classification, and expression of RAGE gene splice variants

(2007) Barry I. Hudson et al.   FASEB JOURNAL

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

(2007) Marc A. Sidler et al.   INFLAMMATORY BOWEL DISEASES

sRAGE is Elevated in Septic Patients and Associated With Patients Outcome

(2007) Christian Bopp et al.   JOURNAL OF SURGICAL RESEARCH